Insider Trading Activity Genomic Health, Inc. (NASDAQ:GHDX) – insider Sold 3,174 shares of Stock

ME Staff
-
0

Insider Trading Activity For Genomic Health, Inc. (NASDAQ:GHDX)

Phillip G. Febbo , insider of Genomic Health, Inc. (NASDAQ:GHDX) reportedly Sold 3,174 shares of the company’s stock at an average price of 33.57 for a total transaction amount of $106,551.18 SEC Form

Insider Trading History For Genomic Health, Inc. (NASDAQ:GHDX)

  • On 11/8/2012 G Bradley Cole, COO, sold 2,500 with an average share price of $28.62 per share and the total transaction amounting to $71,550.00.View SEC Filing
  • On 11/12/2012 Dean L Schorno, CFO, sold 3,000 with an average share price of $28.00 per share and the total transaction amounting to $84,000.00.View SEC Filing
  • On 11/13/2012 Felix Baker, Director, bought 823,772 with an average share price of $27.81 per share and the total transaction amounting to $22,909,099.32.View SEC Filing
  • On 11/14/2012 Felix Baker, Director, bought 103,167 with an average share price of $27.32 per share and the total transaction amounting to $2,818,522.44.View SEC Filing
  • On 11/21/2012 Felix Baker, Director, bought 229,300 with an average share price of $26.83 per share and the total transaction amounting to $6,152,119.00.View SEC Filing
  • On 11/26/2012 Randall S Livingston, Director, sold 2,000 with an average share price of $27.84 per share and the total transaction amounting to $55,680.00.View SEC Filing
  • On 2/11/2013 Felix Baker, Director, bought 116,360 with an average share price of $28.15 per share and the total transaction amounting to $3,275,534.00.View SEC Filing

    • Analyst Ratings For Genomic Health, Inc. (NASDAQ:GHDX)
    These are 2 Sell Ratings, 4 Hold Ratings, 1 Buy Rating .
    The current consensus rating for Genomic Health, Inc. (NASDAQ:GHDX) is Hold (Score: 1.86) with a consensus target price of $31.83 , a potential (3.36% downside)

    Analyst Ratings History For Genomic Health, Inc. (NASDAQ:GHDX)

    • On 11/2/2015 JMP Securities Boost Price Target of rating Outperform with a price target of $34.00 to $36.00
    • On 2/11/2016 Piper Jaffray Companies Reiterated Rating In-Line with a price target of $32.00 to $31.00
    • On 6/21/2016 Leerink Swann Reiterated Rating Buy
    • On 8/3/2016 Bank of America Corporation Set Price Target of rating Sell with a price target of $28.00
    • On 1/4/2017 Cowen and Company Downgraded rating Outperform to Market Perform with a price target of $35.00 to $34.00
    • On 1/9/2017 Barclays PLC Reiterated Rating Sell with a price target of $27.00
    • On 1/18/2017 Deutsche Bank AG Reiterated Rating Hold with a price target of $31.00

    Recent Trading Activity for Genomic Health, Inc. (NASDAQ:GHDX)
    Shares of Genomic Health, Inc. closed the previous trading session at 32.94 down -0.28 -0.84% with 77,824 shares trading hands.